KLCM Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$661K Sell
48,807
-68,150
-58% -$815K 0.05% 164
2026
Q1
$701K Buy
116,957
+17,592
+18% +$132K 0.06% 142
2025
Q4
$712K Sell
99,365
-1,023,465
-91% -$8.09M 0.06% 133
2025
Q3
$12M Sell
1,122,830
-97,485
-8% -$957K 1.2% 24
2025
Q2
$11.8M Sell
1,220,315
-53,284
-4% -$550K 1.26% 23
2025
Q1
$19M Buy
1,273,599
+45,950
+4% +$707K 2.22% 9
2024
Q4
$18.3M Buy
1,227,649
+11,652
+1% +$190K 2.12% 9
2024
Q3
$23.3M Buy
1,215,997
+18,879
+2% +$391K 2.76% 8
2024
Q2
$24.8M Sell
1,197,118
-44,677
-4% -$888K 3.06% 5
2024
Q1
$23.3M Buy
1,241,795
+242,696
+24% +$4.16M 3% 6
2023
Q4
$14.4M Buy
999,099
+376,055
+60% +$5.12M 2.22% 17
2023
Q3
$10.8M Buy
623,044
+272,461
+78% +$5.68M 2.03% 18
2023
Q2
$7.3M Buy
350,583
+45,728
+15% +$994K 1.43% 28
2023
Q1
$7.17M Buy
+304,855
New +$8.19M 1.42% 26
2021
Q3
Sell
-26,297
Closed -$796K 121
2021
Q2
$796K Buy
+26,297
New +$866K 0.18% 52

Other funds holding OGN

KLCM Advisors's OGN Position: Q2 2026 in Review

KLCM Advisors reduced its Organon & Co (OGN) stake by 58% in Q2 2026, selling an estimated $815K and leaving 48,807 shares worth $661K. The position accounts for 0.05% of the portfolio, ranked #164.

KLCM Advisors first reported a position in OGN in Q2 2021 and has held it in 15 quarters since. The position peaked at $24.8M in Q2 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • KLCM Advisors held 48,807 shares of Organon & Co worth $661K as of Q2 2026.
  • KLCM Advisors sold 68,150 Organon & Co shares in Q2 2026, an estimated $815K.
  • Organon & Co made up 0.05% of KLCM Advisors's portfolio in Q2 2026, its #164 holding.
  • KLCM Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 15 quarters since.
  • KLCM Advisors's Organon & Co position peaked at $24.8M in Q2 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on KLCM Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.